DR. MICHAEL GERARD MCCUSKER M.D. NPI 1043605975

NPI Information

  • NPI: 1043605975
  • Provider Name: DR. MICHAEL GERARD MCCUSKER, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 400 CAMPUS BLVD STE 100
    WINCHESTER, VA
    ZIP 22601
  • Phone: (540) 662-1108

Map and Directions

Get Directions

NPI Details

DR. Michael Gerard Mccusker, M.D. is a hematology and oncology internal medicine in Winchester, VA with 21 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Michael Gerard Mccusker, M.D. NPI is 1043605975. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
Graduation Year:2005

The provider's business location address is:

400 CAMPUS BLVD STE 100
WINCHESTER, VA
ZIP 22601-906
Phone: (540) 662-1108
Fax: (540) 667-3408

The NPI 1043605975 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Cyclophosphamide, 100 mg (HCPCS:J9070)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Unclassified drugs (HCPCS:J3490)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Blood creatinine level (HCPCS:82565)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Uric acid level, blood (HCPCS:84550)
  • Administration of prolonged chemotherapy into vein (HCPCS:96416)
  • Magnesium level (HCPCS:83735)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Advance care planning, first 30 minutes (HCPCS:99497)

The enumeration date for this NPI number is 3/30/2015 and was last updated on 5/24/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology0101271135VIRGINIAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.